August 26, 2021, TBDWG Meeting (online)

August 26, 2021

During this meeting, TBDWG members will focus on plans to develop the next report due December 2022 on federal tick-borne activities and research, taking into consideration the 2018 and 2020 reports.

Federal Register Notice

Written Public Comment

Meeting Summary

AGENDA
Time Meeting Item Presenter
9:00 am – 9:10 am Welcome from the Working Group Co-chairs and overview of the agenda Co-Chair Co-Chair
9:10 am – 9:40 am Official Welcome and Swearing in of Members Jim Berger, HHS/OASH
Designated Federal Officer

Dr. Rachel L. Levine
Assistant Secretary for Health (OASH)
9:40 am – 10:10 am Member Introductions Working Group Members
10:10 am – 10:15 am Overview of the Working Group’s Mission, Vision Statement, Values Jim Berger, DFO
10:15 am – 10:20 am Review of Charter, Roles and Responsibilities of the Working Group and Voting Procedures Jim Berger, DFO
10:20 am – 10:35 am Discuss 2022 TBDWG Objective Co-Chair Co-Chair
10:35 am – 10:45 am BREAK  
10:45 am – 11:30 am Public Comments  
11:30 am – 12:15 pm
  • National Strategy for Vector-Borne Disease Prevention and Control
  • LymeX update
    • Kristen Honey, HHS
  
12:15 pm – 1:00 pm Lunch  
1:00 pm – 1:30 pm Discussion on timeline for the 2022 TBDWG Report to Congress Co-Chair Co-Chair
1:30 pm – 1:45 pm Public Comment Subcommittee Discussion
  • Is there agreement to keep the subcommittee
  • Ask for volunteers for subcommittee
 Co-Chair Co-Chair
1:45 pm – 4:30 pm Discuss report topics, ideas and potential subcommittees
  • Federal Inventory Subcommittee Discussion
  • Discuss and Vote on Need for Subcommittee Types and Number of Subcommittees
– call for vote, if ready
  • Discuss and Vote on Processes for:
    - Identification of Subcommittee Members and
        Selection of Subcommittee Members
    - How to Ensure Membership is a Balanced
       Coordination of Efforts with Working Group
 Co-Chair Co-Chair
4:30 pm – 4:45 pm Recap of decisions made
Next Steps		  
4:45 pm Adjourn  
Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed